Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness.
Community Ment Health J
; 59(2): 345-356, 2023 Feb.
Article
em En
| MEDLINE
| ID: mdl-35906435
ABSTRACT
Most people with co-occurring opioid use disorder (OUD) and mental illness do not receive effective medications for treating OUD. To investigate perspectives of adults in a publicly-funded mental health system regarding medications for OUD (MOUD), we conducted semi-structured telephone interviews with 13 adults with OUD (current or previous diagnosis) receiving mental health treatment. Themes that emerged included perceiving or using MOUDs as a substitute for opioids or a temporary solution to prevent withdrawal symptoms; negative perceptions about methadone/methadone clinics; and viewing MOUD use as "cheating". Readiness to quit was important for patients to consider MOUDs. All participants were receptive to discussing MOUDs with their mental health providers and welcomed the convenience of receiving care for their mental health and OUD at the same location. In conclusion, clients at publicly-funded mental health clinics support MOUD treatment, signaling a need to expand access and build awareness of MOUDs in these settings.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Buprenorfina
/
Transtornos Relacionados ao Uso de Opioides
Tipo de estudo:
Qualitative_research
Limite:
Adult
/
Humans
Idioma:
En
Revista:
Community Ment Health J
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Estados Unidos